VKTX smart money
Viking Therapeutics, INC. (VKTX): 1 insider buy, 6 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$150k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-03-10 | Aubuchon Neil William | Chief Commercial Officer | $150k | $33.5 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 15 | Logos Global Management LP | BUY | 0.39% | $6M |
| 51 | Dafna Capital Management LLC | TRIM -8% | 0.38% | $2M |
| 63 | Vestal Point Capital, LP | TRIM -57% | 0.24% | $10M |
| 76 | Polar Capital Holdings PLC | BUY | 0.03% | $11M |
| 86 | Adar1 Capital Management, LLC | ADD +80% | 1.57% | $34M |
| 96 | Pfm Health Sciences, LP | TRIM -26% | 0.66% | $6M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Biotech ETF | ADD | +$48M | 2026-06-30 |